POST Online Media Lite Edition


Becton Dickinson offers EU concessions over $24 billion Bard deal

Staff Writer |
U.S. medical equipment supplier Becton Dickinson and Co. has offered concessions to address EU antitrust concerns over its $24 billion bid for U.S. peer Bard.

Article continues below

The deal, announced in April, is the latest in the medical device sector as companies seek to offset slowing revenue growth, consolidation among healthcare providers and rising pressure from customers to hold down treatment costs.

Becton Dickinson submitted its concessions on Sept. 27, a filing on the EU competition authority showed. It did not provide details, in line with its policy.

The Commission extended its deadline for a decision to October 18 from October 4. It can demand more concessions or open a full-scale investigation of about four months if the companies fail to allay its concerns.

What to read next

Becton Dickinson eyes $600 million revenue from China
Fox seeks EU's okay for $14.4 billion Sky takeover
Pfizer has green light from EU for $15 billion Hospira acquisition